Figure 6 shows the average SHG signal generated per image at 1 and 2 months after CXL. The SHG decreases significantly with depth (by 52.6% in control corneas [
P < 0.01] and 24.5% in CXL corneas on average [
P < 0.01], from anterior to posterior corneas), which is due to the scattering and attenuation of light inside the cornea. Although in control corneas there were no significant differences at 1 and 2 months after CXL in any corneal section (
P > 0.05), SHG signal was significantly higher at 2 months than at 1 month after treatment in both CXL treatments and in all corneal sections (by 11.3%/2.7% [
P < 0.01,
P < 0.01] in the anterior, 8.1%/5.7% [
P < 0.01,
P < 0.01] in the intermediate and 9.5%/13.0% [
P < 0.01,
P < 0.01] in the posterior for UVX/RGX, respectively). In general, the SHG signal for RGX corneas was higher than for UVX (18% at 1 month [
P < 0.01], 12.5% at 2 months [
P < 0.01], total cornea average), and higher than the control, except for the anterior section in the 1-month (15.5% at 1 month [
P < 0.01], and 20.4% at 2 months [
P < 0.01], total cornea average). The SHG signal for UVX was significantly higher than the control only in the posterior stroma (14.9% at 1 month [
P < 0.01], and 22.3% at 2 months [
P < 0.01]) and the intermediate stroma at 2 months (7.7% at 2 months [
P < 0.01]). Otherwise, the average SHG signal of the UVX treated corneas was not significantly different (intermediate 1 month, anterior 2 month,
P > 0.05) or lower than in control corneas (10.5%, anterior at 1 month [
P < 0.01]).